These seven EV battery stocks span lithium, recycling, battery systems, and next-generation cell technology, ranked by overall investment quality rather than pure thematic hype.
EV batteries remain one of the most important industrial buildout stories in the market because the value chain is still being assembled across mining, refining, materials, cells, packs, and recycling. Automakers and battery manufacturers are still pushing for lower-cost, higher-density, and more local supply, while governments continue to support domestic manufacturing capacity. That means investors are not limited to finished battery makers alone. The opportunity set stretches from lithium chemicals and graphite anodes to battery systems and end-of-life recovery, with each link potentially benefiting as EV adoption rises and supply chains become more regional.
The theme is broad, but the details matter. Structural tailwinds include continued EV penetration, the shift toward LFP and high-nickel chemistries, and policy support for North American battery manufacturing and recycling. Recent developments also show why investors need to focus on execution, not just story stocks: NOVONIX said in 2025 that Stellantis terminated a prior offtake agreement, underscoring how quickly commercial relationships can reshape the anode-material landscape, while Li-Cycle continues to emphasize the importance of processing growing volumes of end-of-life and scrap batteries as feedstock availability expands.
In this list, we focus on battery-related companies with direct exposure to the EV battery ecosystem, but we rank them by investment quality rather than hype. That means balancing business relevance against profitability, growth, analyst sentiment, and financial durability. The countdown runs from #7 to #1, with the most compelling overall pick appearing at the end. Some names here are still early-stage and speculative, while others already have meaningful revenue and stronger operating profiles, so the ranking reflects that difference.
For this screen, we started with US-listed companies tied directly to EV batteries, battery materials, battery systems, or recycling, then emphasized investment quality as the ranking criterion. We looked at market capitalization, profitability, revenue scale, growth trends, earnings execution, analyst sentiment, and our composite quality grade. While the broader universe constraint was US-listed companies with market caps above $500 million, a few smaller names remain relevant to the theme and are included because of their direct battery exposure. This is a countdown, so the strongest overall pick is revealed at #1.
What they do. The company is a lithium-ion battery recycler operating in North America, focused on recovering battery materials and metals from used batteries and manufacturing scrap. Its product slate includes lithium, nickel, cobalt, graphite, copper, and aluminum, plus hub products such as lithium carbonate, cobalt sulphate, nickel sulphate, and manganese carbonate. That makes Li-Cycle one of the more direct public-market ways to invest in the recycling side of the EV battery chain.
Why it fits. Battery recycling is a core sub-theme inside EV batteries because rising EV penetration should eventually create larger streams of end-of-life packs and production scrap. Li-Cycle is directly tied to that trend, with a business model built around recovering critical materials that can be reused in battery supply chains. In a market increasingly focused on domestic sourcing and circular supply, that positioning is strategically relevant even if the financial profile remains weak.
Numbers that matter. Revenue was $27.4 million, and year-over-year revenue growth was 78.7%, so the top line is moving in the right direction. But profitability is still deeply challenged: EBITDA was negative $108.5 million, gross margin was negative 188.0%, operating margin was -3.0, and return on equity was -0.4258. EPS over the trailing twelve months was -5.58, with next-year EPS estimated at -2.3192. For a company with only a $29.9 million market cap, that combination makes Li-Cycle a highly speculative turnaround rather than a quality compounder.
Recent momentum. Earnings execution has been inconsistent, with the company beating estimates in only 2 of its last 8 reported quarters. The most recent quarter on 2024-11-08 missed badly, with EPS of -1.8491 versus an estimate of -0.6598, a surprise of -180.3%. Analyst sentiment is still constructive on paper, with a 3.5 consensus and an average target of $2.25, but the split of 1 Buy and 1 Hold shows limited coverage and limited conviction.
What they do. Livent manufactures lithium compounds used in batteries and other specialty applications. Its battery-facing portfolio includes battery-grade lithium hydroxide for high-performance lithium-ion batteries, along with lithium carbonate and lithium chloride used as feedstocks. Compared with earlier-stage battery technology names, Livent is a more mature specialty chemicals supplier with real scale and established end-market relevance.
Why it fits. Lithium compounds remain foundational to the EV battery value chain, and Livent sits upstream where chemistry quality and processing capability matter. The company is especially relevant to investors who want exposure to battery materials rather than cell manufacturing risk. Because it sells battery-grade lithium hydroxide and related compounds, it offers direct participation in EV battery demand without depending on one specific automaker or cell platform.
Numbers that matter. Livent generated $920.1 million in revenue and $473.8 million in EBITDA, which is far stronger scale than most names on this list. Profitability is also the standout: gross margin was 43.3%, operating margin was 0.4182, net margin was 0.4077, return on equity was 0.2424, and return on assets was 0.1271. The stock traded at 9.1722 times trailing earnings and 8.0906 times forward earnings based on the data provided. The main soft spot is growth, with revenue down 8.7% year over year, though earnings growth was still positive at 13.5%.
Recent momentum. Livent has a strong recent earnings record, beating estimates in 7 of its last 8 quarters. The only miss in that stretch came on 2023-10-31, when EPS of $0.44 came in slightly below the $0.46 estimate, a -4.3% surprise. Analyst sentiment is mixed but still constructive overall, with a 4.375 consensus, an average target of $22.52, and a breakdown of 1 Buy, 3 Holds, and 1 Sell. That profile suggests investors respect the business quality even if lithium pricing and demand cycles remain a concern.
What they do. NOVONIX is a battery technology and materials company spanning battery anode materials, battery cell testing equipment, consulting, and graphite exploration. Its business is broader than a single product line, with exposure to both battery materials and the tools used by battery developers. That gives it a differentiated place in the ecosystem, especially for investors interested in anode materials and battery R&D infrastructure.
Why it fits. Anode materials are a critical part of EV battery performance, and NOVONIX is directly exposed through its battery materials segment. The company also fits the theme because testing equipment and development services are essential as cell makers push for better density, durability, and manufacturing consistency. Still, the theme context also highlights a key risk here: commercial contracts can shift quickly, and NOVONIX itself said in 2025 that Stellantis terminated a prior offtake agreement.
Numbers that matter. NOVONIX is still very early financially, with revenue of just $5.6 million and EBITDA of negative $48.3 million. Revenue declined 10.1% year over year, EPS over the trailing twelve months was -0.47, return on equity was -0.6197, and return on assets was -0.1282. Gross margin was 55.5%, but that is overwhelmed by an operating margin of -9.2061, showing that the company is far from scale efficiency. This is a technology story first and a proven operating story second.
Recent momentum. The recent earnings record is mixed, with beats in 3 of the last 8 quarters. Two of the more meaningful updates were better than expected, including EPS of -0.03 versus an estimate of -0.3347 on 2025-08-20 and EPS of -0.09 versus an estimate of -0.3772 on 2025-02-28. Analyst sentiment is unusually bullish in the aggregate, with a 5.0 consensus and an average target of $3, but that optimism sits alongside a composite quality grade of C and weak operating metrics, so investors should treat it as high-risk upside rather than stable quality.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do. Amprius develops and manufactures lithium-ion batteries for mobility applications under its SiCore and SiMaxx platforms. Its products are built around silicon anode technology and are used primarily in aviation applications such as drones and high-altitude pseudo satellites. While that is not pure passenger-EV exposure, it is still a battery technology company focused on high-performance energy storage where density matters.
Why it fits. The EV battery theme is not only about current auto volumes; it is also about next-generation battery architectures and materials. Amprius fits because silicon anode technology is directly relevant to the industry's push for higher energy density. Investors looking beyond commodity materials may see Amprius as a way to gain exposure to advanced cell design, though its current commercial footprint is still narrower than more established battery suppliers.
Numbers that matter. Revenue reached $90.3 million, and year-over-year revenue growth was 152.9%, one of the strongest growth rates on this list. The company is not yet profitable, with a net margin of -0.4398, operating margin of -0.2343, return on equity of -0.4416, and EBITDA of negative $17.0 million, but the loss profile is less extreme than some earlier-stage peers. Gross margin was positive at 18.1%, and analysts expect EPS to improve from -0.31 over the trailing twelve months to 0.058 next year. That combination of rapid growth and a path toward positive EPS is why Amprius ranks in the upper half despite a weak quality grade.
Recent momentum. Amprius has beaten earnings estimates in 6 of its last 8 quarters, showing fairly solid execution versus expectations. The most recent report on 2026-05-07 was a setback, with EPS of -0.04 versus an estimate of -0.015, a -166.7% surprise, but the prior quarter delivered a 79.4% positive surprise. Analyst sentiment remains favorable, with a 4.4286 consensus, an average target of $22.125, and a breakdown of 2 Buys and 1 Hold.
What they do. Enovix designs, develops, and manufactures lithium-ion battery cells. Its customer and application exposure spans wearables, IoT, smartphones, computing, EVs, and OEMs, giving it a broader battery platform than some niche technology peers. That breadth matters because it allows the company to commercialize battery innovation across multiple electronics and mobility categories rather than relying on a single end market.
Why it fits. Enovix belongs on an EV battery list because it is a direct battery cell developer with explicit EV exposure in its end markets. More broadly, it gives investors access to cell-level innovation, which is where improvements in density, safety, and form factor can create strategic value. It also benefits from the same industry push toward better-performing batteries across mobility and connected-device ecosystems.
Numbers that matter. Enovix generated $34.3 million in revenue, with year-over-year revenue growth of 49.1%. Gross margin was positive at 21.5%, but the company remains heavily loss-making, with EBITDA of negative $141.9 million, operating margin of -5.7757, return on equity of -0.7131, and return on assets of -0.1668. EPS over the trailing twelve months was -0.81, and next-year EPS is estimated at -0.5725, which points to improvement but not profitability. Relative to other development-stage battery names, the revenue growth and gross margin are encouraging, but the operating losses are still substantial.
Recent momentum. This is one of the cleaner earnings-execution stories in the group. Enovix has beaten estimates in 7 straight reported quarters, including EPS of -0.14 versus an estimate of -0.15 on 2026-05-13 and EPS of -0.11 versus an estimate of -0.19 on 2025-02-18. Analyst sentiment is supportive, with a 4.5385 consensus, an average target of $13.1, and a split of 2 Buys and 2 Holds. That combination of repeated estimate beats and strong top-line growth helps offset the weak composite quality grade.
Pick #2Subscribers only
Subscribers see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Subscribers get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
This list was built from US-listed companies with direct exposure to the EV battery ecosystem, including battery materials, cell technology, battery systems, and recycling. We then ranked the names primarily by investment quality using primary-source financial data and composite metrics, with attention to market capitalization, revenue base, profitability, growth, earnings consistency, and analyst sentiment. Because this article refreshes monthly, we emphasize evergreen business and financial statistics rather than short-lived price action in the main ranking logic. The result is a countdown from #7 to #1, with the final name representing our strongest overall blend of thematic relevance and investable quality.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
